Dr. Iain Konigsberg is a computational and statistical geneticist whose work focuses on developing predictive models of complex diseases through the integration of large-scale genetic and multi-omic data. He is a Research Scientist in the Department of Biomedical Informatics at the University of Colorado – Anschutz Medical Campus, where he also earned his PhD in Human Medical Genetics & Genomics. His research centers on chronic respiratory diseases, including Chronic Obstructive Pulmonary Disease (COPD), and extends to cardiovascular and metabolic conditions. Dr. Konigsberg is an active contributor to several NIH-funded research consortia, including the Trans-Omics for Precision Medicine (TOPMed) Initiative, where he was named a 2023 Fellow, the Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium, and Definition, Etiology, Function: INtegration to Enhance Type 2 Diabetes (DEFINE-T2D). He also serves as Chair of the Population Descriptors, Social, and Ethical Implications (POPSEI) Working Group within PRIMED, promoting responsible and inclusive approaches to genetic research.
Search for Iain Konigsberg, PhD.'s papers on the Research page